当前位置: X-MOL 学术Front. Life Sci. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Six-ingredient-Xiao-qing-long decoction inhibited TGF-β1-induced proliferation and migration of human airway smooth muscle cells by regulating FKBP51/AKT signaling
Frontiers in Life Science ( IF 1.333 ) Pub Date : 2021-01-20 , DOI: 10.1080/26895293.2021.1875055
Xiufeng Chen 1 , Yonghong Jiang 1 , Wen Li 1 , Xiao Li 1 , Yan Lin 1 , Xiuxiu Liu 1 , Zhiyan Jiang 1 , Zhen Xiao 1
Affiliation  

Abnormal proliferation and migration of human airway smooth-muscle cells (hASMC) play crucial roles in child asthma. We investigated the effect of Six-ingredient-Xiao-qing-long decoction (SXD) on the transforming growth factor (TGF)-β1-stimulated hASMC. Cell viability and migration of TGF-β1-induced hASMC were determined by CCK-8 and transwell assays. The expressions of FK506 binding protein 51 (FKBP51), protein kinase B (AKT), p-AKT were determined by RT-qPCR and western blotting. In addition, FKBP51 overexpression (oeFKBP51) and FKBP51 knockdown (siFKBP51) were carried out to further confirm the results. SXD dose-dependently suppressed the cell proliferation and migration of TGF-β1-induced hASMC. TGF-β1 markedly inhibited the mRNA and protein levels of FKBP51 in a time-dependent manner. Nevertheless, compared to the TGF-β1 group, SXD increased the expression of FKBP51 while suppressed p-AKT. Moreover, both oeFKBP51 and SXD reduced the migration ability of TGF-β1-induced hASMC, as well as elevated the expressions of FKBP51 but decreased p-AKT. Finally, siFKBP51 promoted cell migration and caused the up-regulation of p-AKT in hASMC, but SXD could reverse these changes. SXD could suppress the proliferation and migration of hASMC via activating FKBP51/AKT signaling, which may provide a novel possible target for child asthma therapy.

Abbreviations: SXD, Six-ingredient-Xiao-qing-long decoction; hASMC, human airway smooth muscle cells; TGF-β1, transforming growth factor β1; ECM, extracellular matrix; ERK, extracellular signal-regulated kinase; JNK, C-Jun NH(2)-terminal kinase; FKBP51, FK506 binding protein 51; TCM, traditional Chinese medicine; oeFKBP51, FK506 binding protein 51 overexpression; PI3K, phosphatidylinositol 3-kinase; AKT, protein kinase B; p-AKT, phosphorylation AKT; qRT-PCR, real-time fluorescence quantitative PCR; TCM, traditional Chinese medicine; CCK-8, Cell Counting Kit-8, SRA, Steroid-resistant asthma



中文翻译:

六成分小清龙汤通过调节FKBP51 / AKT信号传导抑制TGF-β1诱导的人气道平滑肌细胞增殖和迁移

人气道平滑肌细胞(hASMC)的异常增殖和迁移在儿童哮喘中起关键作用。我们调查的影响六成分-小庆龙煎剂(SXD)的转化生长因子(TGF) - β 1刺激HASMC。通过CCK-8和transwell测定法测定TGF- β1诱导的hASMC的细胞存活力和迁移。RT-qPCR和Western blotting检测FK506结合蛋白51(FKBP51),蛋白激酶B(AKT),p-AKT的表达。另外,进行FKBP51过表达(oeFKBP51)和FKBP51敲低(siFKBP51)以进一步证实结果。SXD剂量依赖性地抑制了TGF- β1诱导的hASMC的细胞增殖和迁移。转化生长因子1以时间依赖性方式显着抑制FKBP51的mRNA和蛋白质水平。然而,与TGF- β1组相比,SXD增加了FKBP51的表达,而抑制了p-AKT。此外,oeFKBP51和SXD均降低了TGF- β1诱导的hASMC的迁移能力,并提高了FKBP51的表达但降低了p-AKT。最终,siFKBP51促进了细胞迁移并引起了hASMC中p-AKT的上调,但SXD可以逆转这些变化。SXD可以通过激活FKBP51 / AKT信号转导抑制hASMC的增殖和迁移,为儿童哮喘治疗提供新的靶点。

缩写: SXD,六成分小青龙汤;hASMC,人气道平滑肌细胞;TGF- β1,转化生长因子β1;ECM,细胞外基质;ERK,细胞外信号调节激酶;JNK,C军NH(2)端激酶;FKBP51,FK506结合蛋白51;中医药;oeFKBP51,FK506结合蛋白51过表达; PI3K,磷脂酰肌醇3-激酶;AKT,蛋白激酶B;p-AKT,磷酸化AKT;qRT-PCR,实时荧光定量PCR;中医药;CCK-8,细胞计数试剂盒8,SRA,类固醇抗性哮喘

更新日期:2021-01-20
down
wechat
bug